Jerome Roncalli, MD, PhD1; Matthieu Godin, MD2; Kamel Boughalem, MD3; John Shayne, MD4; Christophe Piot, MD, PhD5; Bruno Huret, MD6; Loic Belle, MD7; Guillaume Cayla, MD, PhD8; Benjamin Faurie, MD9; Max Amor, MD10; Bernard Karsenty, MD11; Florence Leclercq, MD, PhD12
Jerome Roncalli, MD, PhD1; Matthieu ...
Prolonged dual-antiplatelet therapy in high bleeding risk (HBR) patients undergoing percutaneous coronary intervention can be challenging. We assessed the clinical safety of bare-metal stent implantation followed by drug-coated balloon...
Prolonged dual-antiplatelet therapy in high bleeding risk (HBR) patients undergoing percutaneous coronary intervention can be challenging. We assessed the clinical safety of bare-metal stent implantation followed by drug-coated balloon...